Schneider, Raphael https://orcid.org/0000-0003-1776-2418
Oh, Jiwon
Article History
Accepted: 7 September 2022
First Online: 27 October 2022
Declarations
:
: Dr. Raphael Schneider received grants from the MS Society of Canada and the J.P. Bickell Foundation. Dr. Schneider has received consulting fees from Biogen-Idec and Novartis. Dr. Schneider has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Biogen-Idec, Sanofi-Genzyme, and EMD-Serono. Dr. Schneider has participated on advisory boards for Novartis and BMS. Dr. Schneider has received support to attend a scientific meeting from EMD-Serono. He is on the editorial board of Frontiers in Neurology.Dr. Jiwon Oh has received grants from the MS Society of Canada, Biogen-Idec, Brain Canada, Roche, the NIH, and EMD-Serono. Dr. Oh has received consulting fees from Biogen-Idec, BMS, Sanofi-Genzyme, Novartis, EMD-Serono,Eli Lilly, and Roche. Dr. Oh has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Biogen-Idec, Roche, Sanofi-Genzyme, Novartis, and EMD-Serono. Dr. Oh has participated on advisory boards for Sanofi-Genzyme, EMD-Serono, Roche, Novartis, Biogen-Idec, and BMS. She is the MS Society of Canada Medical Advisory Committee Chair.
: This article does not contain any studies with human or animal subjects performed by any of the authors.